Fuentealba Rodrigo A, Barría Maria Ines, Lee Jiyeon, Cam Judy, Araya Claudia, Escudero Claudia A, Inestrosa Nibaldo C, Bronfman Francisca C, Bu Guojun, Marzolo Maria-Paz
FONDAP Center for Cell Regulation and Pathology (CRCP), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Mol Neurodegener. 2007 Jul 9;2:14. doi: 10.1186/1750-1326-2-14.
The generation of the amyloid-beta peptide (Abeta) through the proteolytic processing of the amyloid precursor protein (APP) is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies highlight APP endocytosis and localization to lipid rafts as important events favoring amyloidogenic processing. However, the precise mechanisms underlying these events are poorly understood. ApoER2 is a member of the low density lipoprotein receptor (LDL-R) family exhibiting slow endocytosis rate and a significant association with lipid rafts. Despite the important neurophysiological roles described for ApoER2, little is known regarding how ApoER2 regulates APP trafficking and processing.
Here, we demonstrate that ApoER2 physically interacts and co-localizes with APP. Remarkably, we found that ApoER2 increases cell surface APP levels and APP association with lipid rafts. The increase of cell surface APP requires the presence of ApoER2 cytoplasmic domain and is a result of decreased APP internalization rate. Unexpectedly, ApoER2 expression correlated with a significant increase in Abeta production and reduced levels of APP-CTFs. The increased Abeta production was dependent on the integrity of the NPxY endocytosis motif of ApoER2. We also found that expression of ApoER2 increased APP association with lipid rafts and increased gamma-secretase activity, both of which might contribute to increased Abeta production.
These findings show that ApoER2 negatively affects APP internalization. However, ApoER2 expression stimulates Abeta production by shifting the proportion of APP from the non-rafts to the raft membrane domains, thereby promoting beta-secretase and gamma-secretase mediated amyloidogenic processing and also by incrementing the activity of gamma-secretase.
通过淀粉样前体蛋白(APP)的蛋白水解加工生成β淀粉样肽(Aβ)是阿尔茨海默病(AD)发病机制中的核心事件。最近的研究强调APP的内吞作用以及定位于脂筏是有利于淀粉样生成加工的重要事件。然而,这些事件背后的确切机制尚不清楚。载脂蛋白E受体2(ApoER2)是低密度脂蛋白受体(LDL-R)家族的成员,其表现出缓慢的内吞速率并且与脂筏有显著关联。尽管已描述了ApoER2重要的神经生理作用,但关于ApoER2如何调节APP的运输和加工却知之甚少。
在此,我们证明ApoER2与APP发生物理相互作用并共定位。值得注意的是,我们发现ApoER2增加细胞表面APP水平以及APP与脂筏的结合。细胞表面APP的增加需要ApoER2胞质结构域的存在,并且是APP内化速率降低的结果。出乎意料的是,ApoER2的表达与Aβ产生的显著增加以及APP-C末端片段(APP-CTFs)水平的降低相关。Aβ产生的增加依赖于ApoER2的NPxY内吞基序的完整性。我们还发现ApoER2的表达增加了APP与脂筏的结合并增加了γ-分泌酶活性,这两者都可能导致Aβ产生增加。
这些发现表明ApoER2对APP内化有负面影响。然而,ApoER2的表达通过将APP的比例从非脂筏转移到脂筏膜结构域来刺激Aβ产生,从而促进β-分泌酶和γ-分泌酶介导的淀粉样生成加工,并且还通过增加γ-分泌酶的活性来实现。